Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaspian Sunrise Regulatory News (CASP)

Share Price Information for Caspian Sunrise (CASP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.30
Ask: 3.40
Change: 0.00 (0.00%)
Spread: 0.10 (3.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.35
CASP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Canamens BNG Funding Announcement

3 Mar 2011 07:00

RNS Number : 2531C
Roxi Petroleum Plc
03 March 2011
 



 

For immediate release 3 March 2011

Roxi Petroleum plc

Canamens BNG Funding Announcement

 

Introduction

Canamens BNG B.V. ("Canamens") has informed Roxi Petroleum that it will not make the final payments of, in aggregate, $11,975,926 due under the second stage of the sale and purchase agreement in connection with BNG Ltd llp ("BNG") approved by Roxi shareholders in November 2009 (the "SPA"). As a consequence the Roxi board believes that, under the terms of the SPA, Canamens will forfeit approximately a 6.25 per cent interest in the BNG Contract Area to Roxi.

As a result, Roxi's interest in the BNG Contract Area is expected to increase from 23.41 per cent to 29.66 per cent and Canamens holding is expected to decrease from 35 per cent to 28.75 per cent, subject to receipt of the necessary government waivers under Kazakh law. Unless otherwise agreed, all shareholders, including Canamens, remain liable to meet the costs of future developments at BNG on a pro rata basis to their participating interests.

Background

 Roxi acquired a 58.41 per cent interest in BNG, and accordingly the BNG Contract Area, in March 2008, when it acquired 59 per cent of Eragon Petroleum Limited ("Eragon") from Baverstock GmbH ("Baverstock"), a company controlled by Kuat Oraziman, a director of Roxi and its largest shareholder.

In January 2009, Roxi entered into the SPA (as subsequently amended) with Canamens to sell, in aggregate, 35 per cent of BNG held by a wholly owned subsidiary of Eragon, BNG Energy BV, in two stages. It was agreed between Baverstock and Roxi that such sales would be out of the 58.41% Roxi interest in BNG, leaving Baverstock with an effective 40.59% interest in BNG irrespective of the transfers of interests to, or from, Canamens. Under the SPA, Canamens acquired a 23 per cent interest in BNG, in return for a $32 million funding commitment plus a cash payment of $2 million . Under the SPA, Canamens was granted an option to invest a further $23 million in return for a further 12 per cent interest in BNG ("Stage 2 Farm-out"). In March 2010, Canamens exercised its option under the Stage 2 Farm-out.

To date Canamens has met initial cash calls under the terms of the Stage 2 Farm-out of, in aggregate, some $9 million. An approved cash call of $1.7 million has not been met and the balance remaining under the Stage 2 Farm-out is $10.28 million.

Impact on the development of BNG

In the short term Canamens' decision not to advance the funds for BNG will have little operational impact as much of the seismic acquisition and processing work has been completed and the publication of an audited portfolio of BNG prospectivity is expected in Q2 2011.

Clearly the longer term development of the BNG asset will require additional funding. Roxi together with Baverstock, who between them would own some 70.25 per cent of the BNG asset will, in due course, seek to raise additional funding from industry sources.

 

Commenting on the announcement, David Wilkes, CEO said:

"We have been aware that Canamens shareholders have been conducting a strategic review of its operations. It is disappointing that Canamens has decided not to invest the full consideration under the agreed terms of the existing sale and purchase agreement."

Commenting on the announcement, Jan Kielland, CEO of Canamens said:

"As a result of Canamens' portfolio strategy the company has decided to refocus its resources. The consequence of this is to crystallize our interest in BNG to 28.75% in accordance with the agreement with Roxi Petroleum.

 

We are looking forward to working in an optimal way alongside our partners to explore and develop the hydrocarbon potential in the BNG block."

 

Enquiries

Roxi Petroleum plc

David Wilkes CEO +7 727 244 0920

 

Matrix Corporate Capital LLP (NOMAD and broker)

Louis Castro / Tim Graham +44 203 206 7000

 

Buchanan Communications (Financial PR)

Tim Thompson / Ben Romney / Chris McMahon +44 207 466 5000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOSNRAWAORRR
Date   Source Headline
25th Apr 20241:08 pmRNSGeneral Meeting Results
24th Apr 20247:00 amRNSIssue of Equity and Option Awards
8th Apr 20247:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
25th Mar 20247:00 amRNSStrategic & Operational Update
16th Feb 20247:00 amRNSBNG Operational update
21st Dec 20237:00 amRNSOperational Update
31st Oct 20237:00 amRNSOperational update
25th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 202312:49 pmRNSGM results
31st Jul 20237:00 amRNSGeneral Meeting & BNG and Caspian Explorer updates
11th Jul 202312:50 pmRNSHolding(s) in Company
10th Jul 20237:00 amRNSBoard change, Posting of the 2022 Results
7th Jul 20237:30 amRNSRestoration- Caspian Sunrise plc
7th Jul 20237:00 amRNSAnnual Report for the Year Ended 31 December 2022
3rd Jul 20237:30 amRNSSuspension - Caspian Sunrise plc
30th Jun 20233:51 pmRNSAGM results
30th Jun 20237:00 amRNSAGM Statement
12th Jun 20237:00 amRNS50% Sale of Caspian Explorer & Operational Update
1st Jun 20239:26 amRNSAGM and 2022 Accounts update
7th Mar 20237:00 amRNSCaspian Explorer contract signed & Dividend update
20th Feb 20237:00 amRNSCaspian Explorer update & Dividend update
30th Jan 20237:00 amRNSDeep well update
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 202311:05 amRNSSecond Price Monitoring Extn
16th Jan 202311:00 amRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSTender Update
12th Jan 20237:00 amRNSThird Monthly Dividend Declaration
22nd Dec 20228:14 amRNSOperational Update
5th Dec 20227:00 amRNSSecond Monthly Dividend Declaration
11th Nov 20227:00 amRNSDividend Details
7th Nov 202211:05 amRNSSecond Price Monitoring Extn
7th Nov 202211:00 amRNSPrice Monitoring Extension
4th Nov 20224:40 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 20227:00 amRNSOperational Update and Dividend Declaration
3rd Oct 20224:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:36 pmRNSPrice Monitoring Extension
26th Sep 202210:14 amRNSReplacement Announcement for Interim Results
26th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
11th Aug 20227:00 amRNSResult of GM
30th Jun 20222:21 pmRNSResult of AGM
30th Jun 20228:53 amRNSOraziman family holdings
27th Jun 20227:00 amRNSAnnual Report and Financial Statements
22nd Jun 20228:32 amRNSUK High Court confirms Capital Reduction
6th Jun 20227:00 amRNSOperational and impact of Russian sanctions update
31st May 20227:00 amRNSNotice of AGM
30th May 20227:00 amRNSUK Oil Company Windfall Tax & Dividend Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.